STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke
Source ↗
👁 0
💬 0
The Food and Drug Administration on Monday approved Bayer’s drug to reduce recurrence of stroke, making available the first in a novel class of medications that hold the promise of preventing blood clots more safely.
Many blood thinners aren’t used in this setting due to the increased risk of bleeding. But Bayer’s drug, which will be sold under the brand name Sunharbo, inhibits a protein called XIa, utilizing a mechanism that’s thought to stop the formation of bad
Many blood thinners aren’t used in this setting due to the increased risk of bleeding. But Bayer’s drug, which will be sold under the brand name Sunharbo, inhibits a protein called XIa, utilizing a mechanism that’s thought to stop the formation of bad
Comments (0)